COMP: meeting archive 2007-2011

This is an archive of the meeting reports from the Committee for Orphan Medicinal Products (COMP) plenary meetings from 2007 to 2011.

Meeting reports - 2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the December 2011 meeting

Reference Number: EMA/COMP/811367/2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the November 2011 meeting

Reference Number: EMA/COMP/883783/2011Summary:

The Committee for Orphan Medicinal Products held its 128th plenary meeting on 8-9 November 2011.

Committee for Orphan Medicinal Products (COMP): Monthly report from the October 2011 meeting

Reference Number: EMA/COMP/811210/2011Summary:

The Committee for Orphan Medicinal Products held its 127th plenary meeting on 5-7 October 2011.

This month the COMP delivered for a first time ever a positive opinion on orphan designation for the treatment of Leigh syndrome, for which no authorised treatments exist in the EU. This syndrome is a very rare and severe disease caused by mutations in mitochondrial respiratory enzymes, leading mainly to neurological deficits and a poor survival for these patients.

Committee for Orphan Medicinal Products (COMP): Monthly report from the September 2011 meeting

Reference Number: EMA/COMP/399956/2011Summary:

The Committee for Orphan Medicinal Products held its 126th plenary meeting on 6-8 September 2011.

Committee for Orphan Medicinal Products (COMP): Monthly report from the July 2011 meeting

Reference Number: EMA/COMP/399953/2011Summary:

The Committee for Orphan Medicinal Products held its 125th plenary meeting on 6-8 July 2011.

During this meeting the Committee agreed to support the initiative to publish the prevalence figures and information on their sources for conditions that have been subject of orphan designations. The initiative aims at increasing transparency on orphan designation and acknowledging the work done for the prevalence calculation in the context of designation, which can be helpful as initial reference for future applications.

Committee for Orphan Medicinal Products (COMP): Monthly report from the June 2011 meeting

Reference Number: EMA/COMP/399950/2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the May 2011 meeting

Reference Number: EMA/COMP/135191/2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the April 2011 meeting

Reference Number: EMA/COMP/135188/2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the March 2011 meeting

Reference Number: EMA/COMP/134956/2011

Committee for Orphan Medicinal Products (COMP): Monthly report from the February 2011 meeting

Reference Number: EMA/COMP/107542/2011 corr.

Committee for Orphan Medicinal Products (COMP): Monthly report from the January 2011 meeting

Reference Number: EMA/781001/2010

Meeting reports - 2010

Committee for Orphan Medicinal Products (COMP): Monthly report from the December 2010 meeting

Reference Number: EMA/773028/2010 Rev.1

Committee for Orphan Medicinal Products (COMP): Monthly report from the November 2010 meeting

Reference Number: EMA/645806/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the October 2010 meeting

Reference Number: EMA/COMP/586816/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the September 2010 meeting

Reference Number: EMA/COMP/383921/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the July 2010 meeting

Reference Number: EMA/COMP/364048/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the June 2010 meeting

Reference Number: EMA/COMP/342322/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the May 2010 meeting

Reference Number: EMA/COMP/270496/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the April 2010 meeting

Reference Number: EMA/COMP/159501/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the March 2010 meeting

Reference Number: EMA/COMP/89960/2010Summary:

The Committee for Orphan Medicinal Products held its 110th plenary meeting on 2-3 March 2010.

Committee for Orphan Medicinal Products (COMP) - Monthly report from the February 2010 meeting

Reference Number: EMA/COMP/42611/2010

Committee for Orphan Medicinal Products (COMP) - Monthly report from the January 2010 meeting

Reference Number: EMA/COMP/1358/12010

Meeting reports - 2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the December 2009 meeting

Reference Number: EMA/COMP/718385/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the October 2009 meeting

Reference Number: EMEA/COMP/617218/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the September 2009 meeting

Reference Number: EMEA/COMP/506723/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the July 2009 meeting

Reference Number: EMEA/COMP/367198/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the June 2009 meeting

Reference Number: EMEA/COMP/344079/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the May 2009 meeting

Reference Number: EMEA/281967/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the May 2009 meeting

Reference Number: EMEA/281967/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the April 2009 meeting

Reference Number: EMEA/COMP/159165/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the March 2009 meeting

Reference Number: EMEA/COMP/27104/2009

Committee for Orphan Medicinal Products (COMP) - Monthly report from the January 2009 meeting

Reference Number: EMEA/COMP/694107/2009

Meeting reports - 2008

Committee for Orphan Medicinal Products (COMP) - Monthly report from the December 2008 meeting

Reference Number: EMEA/666785/2008

Committee for Orphan Medicinal Products (COMP) - Monthly report from the November 2008 meeting

Reference Number: EMEA/COMP/540306/2008

Committee for Orphan Medicinal Products (COMP) - Monthly report from the October 2008 meeting

Reference Number: EMEA/COPM/497503/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the September 2008 meeting

Reference Number: EMEA/COMP/479052/2008

Committee for Orphan Medicinal Products (COMP) - Monthly report from the July 2008 meeting

Reference Number: EMEA/COMP/363132/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the June 2008 meeting

Reference Number: EMEA/COMP/308994/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the May 2008 meeting

Reference Number: EMEA/COMP/260441/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the April 2008 meeting

Reference Number: EMEA/COMP/184029/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the March 2008 meeting

Reference Number: EMEA/COMP/100434/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the February 2008 meeting

Reference Number: EMEA/COMP/44555/08

Committee for Orphan Medicinal Products (COMP) - Monthly report from the January 2008 meeting

Reference Number: EMEA/COMP/609618/07

Meeting reports - 2007

Committee for Orphan Medicinal Products (COMP) - Monthly report from the December 2007 meeting

Reference Number: EMEA/COMP/554248/2007

Committee for Orphan Medicinal Products (COMP) - Monthly report from the November 2007 meeting

Reference Number: EMEA/COMP/521471/2007

Committee for Orphan Medicinal Products (COMP) - Monthly report from the October 2007 meeting

Reference Number: EMEA/COMP/458438/2007

• COMP meeting archive 2012-2014